(Q30394200)

English

Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

21 June 2017

Effectiveness of seasonal 2008-2009, 2009-2010 and pandemic vaccines, to prevent influenza hospitalizations during the autumn 2009 influenza pandemic wave in Castellón, Spain. A test-negative, hospital-based, case-control study (English)

1 reference

Europe PubMed Central

21 June 2017

0 references

2009 swine flu pandemic

0 references

0 references

pandemic prevention

1 reference

based on heuristic

inferred from title

hospitalization

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

influenza pandemic

1 reference

based on heuristic

inferred from title

author name string

Joan Puig-Barberà

1

1 reference

Europe PubMed Central

21 June 2017

Alberto Arnedo-Pena

2

1 reference

Europe PubMed Central

21 June 2017

Francisco Pardo-Serrano

3

1 reference

Europe PubMed Central

21 June 2017

María Dolores Tirado-Balaguer

4

1 reference

Europe PubMed Central

21 June 2017

Silvia Pérez-Vilar

5

1 reference

Europe PubMed Central

21 June 2017

Ester Silvestre-Silvestre

6

1 reference

Europe PubMed Central

21 June 2017

Consuelo Calvo-Mas

7

1 reference

Europe PubMed Central

21 June 2017

Lourdes Safont-Adsuara

8

1 reference

Europe PubMed Central

21 June 2017

Montserrat Ruiz-García

9

1 reference

Europe PubMed Central

21 June 2017

Surveillance and Vaccine Evaluation Group during the autumn 2009 H1N1 pandemic wave in Castellón, Spain

10

1 reference

Europe PubMed Central

21 June 2017

language of work or name

0 references

publication date

25 September 2010

1 reference

Europe PubMed Central

21 June 2017

1 reference

Europe PubMed Central

21 June 2017

28

1 reference

Europe PubMed Central

21 June 2017

47

1 reference

Europe PubMed Central

21 June 2017

7460-7467

1 reference

Europe PubMed Central

21 June 2017

Pandemic potential of a strain of influenza A (H1N1): early findings

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

Critical illness due to 2009 A/H1N1 influenza in pregnant and postpartum women: population based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

Clinical and epidemiologic characteristics of an outbreak of novel H1N1 (swine origin) influenza A virus among United States military beneficiaries

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

The public's response to the 2009 H1N1 influenza pandemic

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

Expected and unexpected adverse effects H1N1 vaccination for health care workers in a university hospital.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

Evaluation of four real-time PCR assays for detection of influenza A(H1N1)v viruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

Multiple imputation: current perspectives

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

Proportion of disease caused or prevented by a given exposure, trait or intervention

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

Effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

What Does the Odds Ratio Estimate in a Case-Control Study?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

Case-control designs in the study of common diseases: updates on the demise of the rare disease assumption and the choice of sampling scheme for controls

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

Does seasonal influenza vaccination increase the risk of illness with the 2009 A/H1N1 pandemic virus?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

Outbreak of 2009 pandemic influenza A (H1N1) at a New York City school.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

Notes from the field: outbreak of 2009 pandemic influenza A (H1N1) virus at a large public university in Delaware, April-May 2009.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

Infection and death from influenza A H1N1 virus in Mexico: a retrospective analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

Partial protection of seasonal trivalent inactivated vaccine against novel pandemic influenza A/H1N1 2009: case-control study in Mexico City

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

Selection bias explains seasonal vaccine's protection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

Why most published research findings are false

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

Selection of controls in case-control studies. I. Principles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

Viral loads and duration of viral shedding in adult patients hospitalized with influenza.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

New strategies are needed to improve the accuracy of influenza vaccine effectiveness estimates among seniors

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

Evidence of bias in studies of influenza vaccine effectiveness in elderly patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

Residual immunity in older people against the influenza A(H1N1)--recent experience in northern Spain.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

Large trials confirm immunogenicity of H1N1 vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

Immunogenicity and safety in adults of one dose of influenza A H1N1v 2009 vaccine formulated with and without AS03A-adjuvant: preliminary report of an observer-blind, randomised trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.042

7 January 2021

Identifiers

10.1016/J.VACCINE.2010.09.042

1 reference

Europe PubMed Central

21 June 2017

1 reference

Europe PubMed Central

21 June 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30394200&oldid=1648453230"